Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study.

Yi-Chih HungLu-Ting ChiuHung-Yu HuangDa-Tian Bau

Published in: Cardiovascular diabetology (2020)

Pioglitazone use decreased the risk of new-onset ischemic stroke in Asian patients with type 2 DM and CV risk factors. Trial registration number CMUH104-REC2-115-CR4.

Keyphrases

cardiovascular risk factors
risk factors
atrial fibrillation
cardiovascular disease
metabolic syndrome
study protocol
clinical trial
phase iii
phase ii
type diabetes
randomized controlled trial
adipose tissue
blood brain barrier
cerebral ischemia